Gross Margin

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

With revenue growth tied to shrinking margins, illumin's upcoming 2025 earnings report is a critical test of its strategy in a shifting ad tech world.

The pizza giant posts robust sales and expands market share, crediting its 'Hungry for MORE' strategy and rewarding investors with a major dividend boost.

Following its NYSE debut, Enigmatig reports strong revenue growth and a massive cash influx, setting the stage for aggressive expansion in Asia and beyond.

Following strong financial results, Andrew Peller Limited sees its second board departure in a year, raising questions about governance and leadership stability.

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

Indian footwear giant Tej International appoints a US-based luxury influencer to reshape its brand, betting on modern storytelling to crack global premium markets.

The drying tech firm's Q1 report shows strong growth and new deals, yet a major revenue miss spooks investors, highlighting its challenging road to profit.

As Home Instead names its 10 Care Pros of the Year, the awards highlight both profound human compassion and the urgent need to address a critical caregiver shortage.

With its 2025 results fresh, Green Plains will outline its strategy for high-value biorefining and renewable fuels at a key BofA conference.

The specialty insurer posted 30% premium growth and a record-low combined ratio, crediting its AI-driven underwriting platform for its success.

MAIA Pharmaceuticals will bring Teribone™, a proven therapy used in Japan, to the US, aiming to solve the critical patient adherence crisis in osteoporosis care.

A new report reveals Americans face a $5 trillion annual bill burden, with essential costs consuming an alarming share of income and pushing families to the brink.

Climbing Entrepreneur's Franchise 500, this Verizon retailer reveals a model built on rapid growth, robust franchisee support, and deep community roots.

Riding a wave of strong earnings, Synaptics executives will outline their vision for AI at the Edge at key investor conferences in the coming weeks.

A new study reveals a breakthrough hair loss system offers clinically meaningful regrowth for menopausal women in just four months, challenging existing treatments.

Klothea Bio's trial for a 'longevity protein' drug in Honduras pushes the boundaries of science, but raises questions about offshore research and equity.

TUDOR answers enthusiast calls with a new 36mm Ranger and a striking 'Dune white' dial, blending vintage appeal with modern technical prowess.

The PXM leader surpassed the coveted 'Rule of 40' financial benchmark in 2025, signaling strong growth and profitability as it preps for an AI-driven future.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.